LOGO
LOGO

Corporate News

Dynavax Urges Stockholders To Re-Elect All Four Director Nominees Ahead Of June 11 Meeting

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News

Dynavax Technologies (DVAX) has urged stockholders to vote in favor of its four board nominees—Brent MacGregor, Scott Myers, Lauren Silvernail, and Elaine Sun—at the upcoming Annual Meeting on June 11, 2025.

The company emphasized that these candidates bring critical expertise in biotech, vaccines, M&A, and financial strategy, vital to its long-term growth.

Dynavax criticized activist investor Deep Track for proposing a "strip-mining" strategy that prioritizes short-term gains over sustainable value creation. The company warned that replacing current board members with Deep Track's less-qualified nominees would undermine its successful repositioning, operational execution, and capital strategy.

Independent proxy advisors ISS, Egan-Jones, and Glass Lewis have endorsed Dynavax's nominees, citing Deep Track's flawed case for change, misleading claims, and the questionable qualifications of its principal, Brett Erkman. ISS and Glass Lewis highlighted the company's 203 percent five-year total return and strong leadership, including the market success of HEPLISAV-B.

Dynavax reminded stockholders that the re-election of its nominees is essential to preserving strategic continuity and urged them to vote using the GOLD proxy card.

Monday, DVAX closed at $10.28 and remained unchanged in after-hours trading on the Nasdaq Global Select Market.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - May 04 – May 08, 2026

May 08, 2026 15:50 ET
Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.

Latest Updates on COVID-19